Based though on the established inclusion criteria only 10% of female individuals receiving genetic testing due to the early onset breast cancer alone (BC at age < 36 years with negative family history) are expected to carry a BRCA1/2 pathogenic variant [2]. This evidence concerns the gene BRCA1 and breast carcinoma.